The motivation is straightforward. Implantable sensors that monitor organs continuously are increasingly seen as a way to catch disease before symptoms appear, but the devices that could enable such monitoring face a fundamental materials problem. Conventional magnetic implants rely on metals such as iron, cobalt or nickel, which raise concerns about long-term toxicity, corrosion, interference with magnetic resonance imaging, and the need for a second surgery to remove them. Metal-free molecular magnets, by contrast, promise biocompatibility and resorbability, yet until now they have lacked the ferromagnetic strength needed for high-fidelity sensing at clinically relevant tissue depths.

The key to the new material lies in a chemical transformation called de-nitrogenation. By removing nitrogen atoms from the graphitic carbon nitride framework, the researchers create unpaired electron spin centres that become coupled through a reconstructed network of alternating pi and sigma conjugated bonds. This coupling confers robust spontaneous magnetization, meaning the material is ferromagnetic at room temperature without any external field, and that magnetization remains stable under physiological conditions. The authors verified the origin of the ferromagnetism theoretically, using first-principles calculations including crystal orbital Hamilton population analysis, and confirmed experimentally that the magnetism is strong enough to produce visible, macroscopic magnetic responses in bulk powder form.

To turn the material into a practical medical platform, the team embedded it in two well-established biodegradable polymers: poly(lactic-co-glycolic acid), or PLGA, and silk fibroin, the protein that gives silk its strength. The resulting composites can be fabricated as flexible epicardial patches that are foldable for catheter delivery. Supplementary videos accompanying the paper show a pre-folded, rose-petal-shaped patch held in a sheath mimicking a catheter lumen; when the sheath retracts, the patch blooms open within seconds, unfolding radially to enlarge its contact area against tissue. This bloomable design allows minimally invasive deployment and conformal attachment to organ surfaces without sutures.

The sensing architecture works in pairs. The internal implant, driven by the mechanical deformation of the organ it sits on, generates a time-varying magnetic flux that passes through the closed chest wall. Outside the body, a skin-interfaced array of Hall-effect sensors captures that flux and converts it into continuous readouts of organ motion. The signals are transmitted wirelessly to a smartphone-linked reader and a cloud-based analytics platform. Because the approach relies on magnetic coupling rather than acoustic, optical or electrical transduction, it requires no coupling gel, no vascular access and no optical alignment, and the authors report that it is robust against motion artifacts and variations in tissue impedance.

The team tested the system in porcine models, the standard large-animal platform for cardiovascular research. Epicardial patches deployed on the heart enabled continuous, untethered monitoring of myocardial dynamics over four weeks, during which the researchers tracked ejection fraction, a key clinical measure of how much blood the heart pumps with each beat. When benchmarked against standard-of-care echocardiography, the magnetic sensing approach delivered trajectories of clinical grade, suggesting it could support longitudinal physiological monitoring outside hospital infrastructure. Cardiac magnetic resonance imaging at day 28 confirmed that the patch remained conformally attached to the epicardium throughout repeated cycles of systolic contraction and diastolic relaxation, without detachment or migration.

Beyond the heart, the researchers showed that the material can be dispersed into injectable hydrogels for organ-scale sensing. Under ultrasound guidance, a BioMFM-integrated sodium alginate hydrogel was injected percutaneously onto the surface of a porcine liver, where the bolus appeared as a distinct hyperechoic region against the liver parenchyma, allowing precise minimally invasive placement. The hydrogel preserved the shear-thinning behaviour needed to flow through narrow-gauge clinical syringes even at loadings up to ten percent by weight, extruding smoothly without clogging. In the liver experiments, the magnetic markers enabled three-dimensional reconstruction of localized hepatic pathologies, pointing toward a future in which injected tracers map disease geometry inside solid organs.

What happens after the monitoring period is arguably the most distinctive feature. The material is designed to bioresorb, degrading benignly once its sensing mission is complete, which eliminates the retrieval surgery that metallic implants require and avoids the chronic foreign-body burden of permanent devices. The authors frame this as part of a broader degradation-by-design strategy in two-dimensional materials, in which chemical functionalization is used to tune biodegradability and safety. In the porcine studies, four weeks of continuous cardiac assessment were followed by benign bioresorption, closing the loop between function and disappearance.

The theoretical foundation of the work draws on a decade of research into metal-free magnetism in carbon nitride. Earlier studies predicted intrinsic half-metallicity and defect-related ferromagnetism in graphitic carbon nitride nanosheets, and recent work achieved strong ferromagnetism through atomic manipulation. The new study extends this line by engineering a molecular magnet whose spontaneous magnetization survives integration into polymer composites and physiological environments, a step that earlier radical-based organic magnets had not reached at clinically useful strength. The authors also employed machine-learning tools from cheminformatics, including ChemBERTa-style pretrained models, in their analysis workflow, and released their analysis code, firmware for an ESP32-S3 microcontroller and installation instructions on GitHub.

The clinical implications reach beyond cardiology. Acute heart failure and post-discharge follow-up after acute coronary syndrome remain areas where continuous, infrastructure-independent monitoring could change outcomes, and existing tools such as pulmonary artery catheters and periodic echocardiography offer only snapshots or require invasive access. A resorbable magnetic patch that reports ejection fraction continuously, read through the skin by a wearable sensor array, could in principle bring intensive-care-grade hemodynamic tracking to ordinary wards or even to patients at home. The injectable hydrogel variant extends the same logic to the liver, where elastography-based stiffness measurements are currently the dominant non-invasive tool but offer limited spatial resolution. The researchers caution that the work is at the large-animal stage, and human translation will require further safety and accuracy studies. Still, the demonstration that a metal-free, fully resorbable molecular magnet can deliver clinical-grade physiological trajectories over weeks marks a notable convergence of molecular magnetism, biodegradable electronics and wireless sensing, and suggests that the next generation of implantable diagnostics may be designed to vanish rather than endure.

Subject of Research: A bioresorbable metal-free molecular magnet for wireless deep-tissue and cardiac monitoring

Article Title: Bioresorbable metal-free molecular magnets enable untethered organ monitoring

Article References: Wu, Y., Yue, Z., Xing, S., Yang, D., Wang, J., Liu, Y., Cohen, H., Liu, L., Jiao, Q., Li, Z., Ali, H., Perera, C., Vahl, T. P., Ranard, L. S., Zhang, Z., Einstein, A. J., Zhang, A., Dashnaw, S., Huang, Y., … Bai, W. (2026). Bioresorbable metal-free molecular magnets enable untethered organ monitoring. Nature Materials. https://doi.org/10.1038/s41563-026-02759-4

Image Credits: AI Generated

DOI: 10.1038/s41563-026-02759-4

Keywords: molecular magnets, graphitic carbon nitride, bioresorbable materials, cardiac monitoring, implantable sensors, Hall effect sensing, ferromagnetism, PLGA, silk fibroin, injectable hydrogels, ejection fraction, Nature Materials

The review, led by researchers surveying the state of the art in wearable, implantable, biodegradable and self-powered biosensing platforms, takes an unusually rigorous approach. Rather than simply cataloguing recent breakthroughs, the authors analysed 144 publications using a bibliometric method, building a quantitative map of the research landscape. The analysis reveals a field that has grown rapidly and become deeply multidisciplinary, drawing on electrochemistry, materials science, microfluidics, wireless engineering and data science. It also charts a decisive transition in ambition: from one-off or periodic measurements toward connected, autonomous sensors that operate reliably for weeks, months or even longer.

At the heart of this transformation lies a quiet revolution in materials. The review systematically examines how advanced functional materials are being engineered to overcome the classic weaknesses of biosensors, which historically traded sensitivity for stability and speed for selectivity. Carbon nanotubes and graphene quantum dots, with their extraordinary electrical conductivity and vast surface areas, enhance charge transfer between the biological recognition element and the electronic transducer, boosting signal strength. MXenes, a family of two-dimensional transition metal carbides and nitrides, and covalent organic frameworks, crystalline porous polymers with tunable chemistry, create pathways that improve analyte accessibility, allowing target molecules to reach the sensing surface more efficiently even in complex samples.

Perhaps most intriguing are the materials designed to solve the selectivity problem, arguably the hardest challenge in biosensing. Molecularly imprinted polymers act as artificial antibodies, with binding cavities sculpted around a template molecule during synthesis, giving them the ability to recognise specific targets amid a crowded biochemical background. Functional polymers and hydrogels add reversible recognition, meaning the sensor surface can release the analyte and be regenerated for the next measurement cycle, a property essential for any device intended to monitor continuously rather than be used once. Chiral composites exploit the handedness of molecules to discriminate between chemically identical mirror-image forms, a subtle but clinically important distinction, while engineered antifouling surfaces resist the protein and cell deposition that would otherwise blind the sensor within hours of deployment.

On the mechanical side, hydrogels and flexible polymers allow devices to conform to the curved, moving surfaces of the human body, maintaining stable contact with skin or tissue without irritation. This mechanical flexibility, combined with biocompatible encapsulation and, in some designs, fully biodegradable architectures, is what turns a laboratory curiosity into a device a patient can genuinely live with. Self-powered designs go further, harvesting energy from bodily motion or bioelectrochemical reactions to eliminate the need for battery replacement, a major barrier for implantables.

The review is careful to stress that materials alone do not make a continuous monitoring system. Electrochemical and optical transduction strategies are examined systematically, since the choice of how a molecular binding event is converted into an electrical or optical signal determines much of the device’s performance envelope. Around that core, the modern biosensor is increasingly a networked computing device. Microfluidic channels deliver and prepare samples at microscopic scales, wireless links transmit data from body or field, and artificial intelligence and machine learning algorithms interpret raw signals, compensate for drift and extract clinically meaningful trends. Edge and cloud computing architectures, tied together through the Internet of Things, are enabling multiplexed platforms that track many biomarkers simultaneously and even close the loop, adjusting a therapy automatically in response to what the sensor measures.

Yet the review’s most sobering contribution may be its honest assessment of the barriers standing between laboratory promise and real-world deployment. Sensor regeneration, the ability to reset the sensing surface without degrading it, remains difficult. Biofouling, the accumulation of biological material on the device, degrades signal quality over time. Signal drift means a sensor calibrated on day one may report falsely by day ten, and matrix interference from proteins, salts and other sample components can swamp the target signal entirely. Calibration strategies, energy demands, biocompatibility, device integration, manufacturing scalability, cybersecurity of connected health devices, regulatory compliance and the scarcity of genuine clinical and field validation all loom as obstacles that laboratory benchmarks routinely understate.

Indeed, one of the review’s most striking arguments is that the traditional figures of merit of analytical chemistry, sensitivity and limit of detection, are simply inadequate for judging whether a biosensor is ready for deployment. A device can post dazzling detection limits in a clean buffer solution and still fail within days in blood, sweat or river water. What matters instead, the authors contend, are long-term stability, tolerance of complex matrices, reproducibility between devices and validation under realistic conditions. Until the field adopts these deployment-oriented metrics alongside conventional ones, lab-to-life translation will remain the exception rather than the rule.

The path forward, as the review sketches it, is correspondingly holistic. Priority directions include regenerative and antifouling sensing interfaces that keep themselves clean and functional, multimodal and self-powered platforms that reduce dependency on external energy, physiomimetic and minimally invasive architectures that the body tolerates better, and AI-enabled signal interpretation that can distinguish true biological trends from artefacts. Equally critical are unglamorous but essential steps: standardized performance metrics that allow honest comparison between devices, scalable manufacturing routes that can bring costs down, and rigorous clinical and environmental validation studies that test devices where they will actually be used.

Taken together, the review’s message is that reliable continuous biosensing will not emerge from any single breakthrough in nanomaterials or transduction chemistry. It demands the coordinated advancement of advanced materials, biorecognition chemistry, device engineering, energy management, digital connectivity and data analytics as an integrated system. If that integration succeeds, the payoff is substantial: personalized healthcare that watches over patients continuously rather than at the discretion of a blood draw schedule, and environmental stewardship that detects contamination as it happens rather than after the fact. The sensors are getting closer to ready. The challenge now is everything around them.

Subject of Research: Continuous monitoring biosensors for healthcare and environmental applications

Article Title: Continuous monitoring biosensors for advanced healthcare and environmental applications: challenges, material innovations and future directions

Article References: Amireddy, K. K., Reddy, P. V. R. R., Reddy, C. N., & Reddy, P. P. (2026). Continuous monitoring biosensors for advanced healthcare and environmental applications: challenges, material innovations and future directions. Frontiers in Sensors, 7, Article 1968999. https://doi.org/10.3389/fsens.2026.1968999

Image Credits: AI Generated

DOI: 10.3389/fsens.2026.1968999

Keywords: biosensors, continuous monitoring, wearables, implantable sensors, MXenes, graphene quantum dots, molecularly imprinted polymers, hydrogels, electrochemical sensors, artificial intelligence, Internet of Things, environmental monitoring

The motivation behind the work is stark. The world generates roughly 50 million tons of electronic waste every year, and according to the United Nations Environment Programme that figure is climbing at about 5 percent annually. The 2024 Global E-Waste Monitor found that the volume of e-waste actually recycled remains far below the volume produced, even though the recoverable value locked inside discarded electronics was estimated at 57 billion US dollars in 2020 and is projected to reach 65.8 billion dollars by 2026. Beyond the lost resources, e-waste leaches heavy metals and persistent organic pollutants into soil and aquatic ecosystems, where they bioaccumulate and threaten human health. For the researchers behind the new material, the answer was not better recycling of toxic components but a redesign of the components themselves.

Piezoelectricity—the ability of certain materials to generate electrical charge when mechanically deformed—has long been attractive for self-powered sensing because it eliminates the need for batteries and external power sources. Piezoresistive and piezocapacitive sensors can be highly sensitive, but they demand continuous external power, complicating system design. Triboelectric generators also harvest mechanical energy but typically require intricate microstructural engineering to perform well. Natural, biodegradable piezoelectric materials such as collagen, chitosan, fish swim bladder, and the amino acid crystal γ-glycine have been explored, yet their piezoelectric coefficients fall substantially below those of ferroelectric ceramics, limiting their usefulness in real sensing applications. The new composite was designed to close exactly that gap.

The key insight lies in pairing two environmentally benign ingredients whose strengths compensate for each other’s weaknesses. The first is TEMPO-oxidized cellulose nanofiber, or TOCNF, extracted from bamboo biomass. Cellulose is renewable, biodegradable, and intrinsically piezoelectric thanks to its non-centrosymmetric crystal structure, but its piezoelectric coefficient of roughly 0.4 pC·N⁻¹ is far too weak for practical devices. The second ingredient is 2,2,3,3,4,4-hexafluoropentane-1,5-diol, abbreviated HFPD, a molecular ferroelectric crystal whose asymmetric distribution of carbon–fluorine bonds creates a strong molecular dipole and a much larger piezoelectric coefficient of about 138 pC·N⁻¹. Pure HFPD, however, is a brittle crystal that cannot be processed into flexible devices on its own. Combining the two in water and letting the solvent evaporate produces a flexible, robust film in which the crystal’s high piezoelectric activity is effectively transferred into the cellulose matrix.

The chemistry that makes this transfer possible is a dense, multilevel hydrogen-bonding network. Carboxylate groups introduced onto the cellulose nanofibers through TEMPO-mediated oxidation interact strongly with the hydroxyl groups of HFPD, creating a hierarchically ordered structure that channels mechanical stress efficiently and keeps molecular dipoles aligned. Density functional theory calculations quantified the strength of this partnership: the calculated binding energy for the HFPD/TOCNF pair was −25.89 kcal·mol⁻¹, considerably stronger than the interactions within HFPD alone (−6.28 kcal·mol⁻¹) or between cellulose fibers themselves (−19.28 kcal·mol⁻¹). Spectroscopic evidence reinforced the picture. Variable-temperature infrared measurements showed a band at about 3250 cm⁻¹ corresponding to strong, ordered hydrogen bonds within two-dimensional HFPD layers, which progressively vanished as the material was heated past its melting point—an order-to-disorder transition that mirrors the crystal’s role in the composite. Raman mapping revealed that the ratio of strong to weak hydrogen bonds jumped from 0.62 in pristine cellulose to 1.67 in the composite.

Composition proved critical. At an optimal HFPD-to-TOCNF mass ratio of 2:1, the film achieved its maximum piezoelectric coefficient of 14.0 ± 1.5 pC·N⁻¹, a more than fivefold improvement over pure cellulose nanofiber films, which measured just 2.55 pC·N⁻¹. Push the HFPD content higher, however, and performance drops. Differential scanning calorimetry revealed a telltale double peak at high loadings, indicating that some HFPD crystallizes outside the cellulose scaffold with random molecular orientations. Those misaligned dipoles cancel one another out, and the team observed a 32 percent reduction in open-circuit voltage at excessive HFPD levels, alongside increased brittleness. The result is a tunable system in which mechanical flexibility and electromechanical output can be balanced simply by adjusting the recipe.

Assembled into a sandwich-structured nanogenerator with copper electrodes and a polylactic acid encapsulation layer, the composite delivered an open-circuit voltage of 8.06 volts and a short-circuit current of 195 nanoamperes under 100 kilopascals of compressive stress—a 91.6 percent improvement in voltage and roughly a fourfold boost in current over pristine cellulose films. Maximum output power reached 1.52 microwatts, corresponding to a power density of 3.80 milliwatts per square meter. The device also proved remarkably durable, retaining 94 percent of its initial mechanical strength and 97 percent of its piezoelectric performance after 100,000 bending cycles. In capacitor-charging tests, the generator brought a 1.0-microfarad capacitor to 2.57 volts within about 400 seconds, demonstrating its potential as a sustainable power source for low-energy wearable electronics.

The sensing demonstrations are where the material becomes genuinely viral-worthy. Stuck to the throat, the sensor captured the subtle muscle contractions of speech, producing distinct voltage signatures for spoken words in different languages, including Mandarin, English, and Thai. Placed near joints, it tracked wrist, elbow, knuckle, and knee flexion with angle-dependent outputs—for example, roughly 0.17, 0.45, and 0.86 volts at wrist bending angles of 30, 60, and 90 degrees—and distinguished fast from slow motion with a temporal resolution of about 0.33 seconds. The team then wired the sensor into Internet of Things platforms and taught it Morse code: short and long finger presses generated dots and dashes, allowing users to transmit emergency messages such as SOS, COLD, PAIN, and HELP. A one-dimensional convolutional neural network trained on 5,000 signal sequences classified ten Morse code letters with 98.7 percent overall accuracy, reaching perfect recognition for several letters—a striking proof of concept for assistive communication among people with speech impairments or limited mobility.

Biocompatibility results support ambitions beyond the skin. In vitro tests with mouse embryonic fibroblast cells showed viability above 100 percent even at the highest tested concentration of 10 micrograms per milliliter, with live/dead staining confirming healthy cell morphology. Miniaturized devices measuring 5 by 10 millimeters were then implanted subcutaneously in rats, where a sensor placed on the quadriceps muscle generated stable outputs exceeding 100 millivolts during limb stretching, and one on the pectoralis major muscle recorded roughly 20-millivolt signals driven by breathing alone. Tail-vein injection of the composite into mice at 80 milligrams per kilogram produced no histological abnormalities in the heart, liver, spleen, lung, or kidney at 24 or 48 hours, with no signs of inflammation, hemorrhage, or edema.

Perhaps the most consequential result is what happens at the end of the device’s life. Because HFPD is water-dispersible and the cellulose network is hydrophilic, a used film completely disintegrates in water within six hours; vacuum filtration recovers crystalline HFPD as a white powder while the filtrate retains dispersible nanocellulose for centrifugation. Regenerated films retained mechanical strength and electrical output essentially unchanged through four recycling cycles, closing the loop without performance loss. In outdoor soil burial tests conducted over 25 days, the HFPD/TOCNF films began fracturing within five days and lost nearly 100 percent of their mass by day 25, while commercial PVDF control films showed no visible degradation or measurable weight change at all. By dissolving the long-standing trade-off between electromechanical performance and lifecycle sustainability, the bamboo-based composite offers a credible template for next-generation green electronics—wearable health monitors, implantable sensors, and human-machine interfaces that work hard while they are needed and quietly return to the earth when they are not.

Subject of Research: A recyclable, biodegradable cellulose-based piezoelectric nanogenerator for self-powered biosensing and human-machine interaction

Article Title: A Recyclable and Biodegradable High‐Performance Piezoelectric Nanogenerator for Self‐Powered Biosensing and Assistive Human‐Machine Interaction

Article References: Luo, T., Xiao, T., Zhang, L., Zhang, B., Lu, S., Xiao, H., Li, J., Liu, K., Chen, C., & Wu, H. (2026). A Recyclable and Biodegradable High‐Performance Piezoelectric Nanogenerator for Self‐Powered Biosensing and Assistive Human‐Machine Interaction. Advanced Science, Article e77780. https://doi.org/10.1002/advs.77780

Image Credits: AI Generated

DOI: 10.1002/advs.77780

Keywords: piezoelectric nanogenerator, cellulose nanofibers, biodegradable electronics, e-waste, self-powered sensors, wearable devices, molecular ferroelectric, hydrogen bonding, Morse code communication, implantable sensors, recyclable materials, human-machine interface

The central engineering challenge is deceptively simple to state. A battery must store and deliver meaningful energy, yet every component—anode, cathode, electrolyte, separator, current collector and packaging—must remain stable during operation and then degrade predictably into products the body can metabolize or excrete. Conventional lithium-ion chemistry fails this test on nearly every count: lithium is reactive, the organic electrolytes are toxic, and the metal casings persist indefinitely. Designing around those constraints requires rethinking the battery from first principles, choosing electrode materials from the palette of biologically tolerated elements and finding ionic chemistries that function in aqueous, physiological environments.

Among the most promising strategies reported in recent work are metal–air and metal-based cells built around magnesium, zinc, iron, molybdenum and tungsten. Zinc, in particular, has attracted attention because it is an essential trace nutrient, electrochemically well behaved in neutral aqueous media, and yields benign zinc ions and hydroxide species upon discharge. Magnesium offers a higher theoretical voltage and specific capacity and is already widely used in biodegradable orthopedic implants, giving clinicians a long safety track record to draw upon. Pairing these metals with cathodes made from oxides, phosphates or even bio-derived molecules such as iodine and quinones allows researchers to assemble complete cells whose every element participates in the body’s normal biochemistry.

Electrolytes present a subtler problem. The medium through which ions shuttle must conduct well, resist premature self-discharge, and dissolve cleanly afterward. Teams have explored hydrogels cross-linked from natural polymers, salt-loaded chitosan membranes, phosphate-buffered solutions held within biodegradable pouches, and solid polymer electrolytes based on polyethylene glycol and polylactic acid. The encapsulation strategy matters as much as the chemistry: a transient battery is only as transient as its slowest-dissolving layer. Researchers have therefore developed multilayer packaging from polyanhydrides, polycaprolactone and silk fibroin, tuning film thickness and crystallinity so that the operational lifetime can be programmed from days to months, much as drug-eluting stents control their release kinetics.

Power output has long been the Achilles heel of resorbable energy storage, since aqueous chemistries deliver lower cell voltages than lithium systems. The field has responded with clever circuit-level solutions. Stacking individual cells in series within a single package boosts voltage to the levels needed by microcontrollers, radios and sensors, while parallel arrays extend operating time. Reports of transient batteries generating on the order of one to a few volts, sufficient to power cardiac pacemakers in large animal models and to drive wireless transmission from implantable sensors, have shifted the conversation from feasibility to engineering refinement. Energy densities approaching levels useful for clinical devices have been demonstrated in packages small enough to fit within the capsule formats familiar from swallowable diagnostics.

The ingestible application is arguably the most immediate. Electronic capsules that sample the gastrointestinal tract, deliver drugs on schedule, or monitor pH, temperature and pressure currently contain rigid, persistent hardware. A power source that dissolves after a defined period means the device can be designed to break apart and pass or absorb without intervention, reducing the risk of retained foreign bodies and simplifying regulatory pathways. Transient batteries have been engineered to survive the acidic environment of the stomach, activate in the intestine, and maintain output long enough to complete a diagnostic or therapeutic mission before their hydrogel electrolytes swell, weaken and finally dissolve into the surrounding fluid.

Implanted applications raise the stakes in different ways. Temporary pacemakers intended to support patients after cardiac surgery, biodegradable sensors for monitoring wound healing, and stimulators for nerve regeneration all require power for days to weeks and none of the encumbrance of permanent hardware. In animal studies, resorbable battery packs have successfully paced hearts at clinically relevant rates and then degraded over weeks with no significant inflammatory response, the degradation products appearing at concentrations well within physiological tolerance. Surgeons and cardiologists watching these demonstrations see a path to devices that avoid the extraction procedures, infections and device erosion complications that complicate conventional implants.

Safety evaluation is where laboratory promise meets biological reality, and the field has been accumulating the necessary evidence. Biocompatibility testing of the constituent materials—zinc, magnesium, molybdenum, tungsten, silk, chitosan, PLGA and related polymers—shows degradation products that are cleared renally or metabolized into water and carbon dioxide. Histological examination of implantation sites typically reveals a mild, transient foreign-body response that resolves as the materials disappear. The critical design parameter is the balance of dissolution rates: the battery must not release its stored electrochemical charge or its degradation products faster than tissue clearance mechanisms can handle, a constraint that drives careful control of surface area, porosity and protective coatings.

Manufacturing and integration remain open questions on the road to commercialization. Many laboratory devices are assembled by hand from foils, films and gels; scaling to consistent, sterile, high-volume production demands reel-to-reel deposition, laser micromachining and packaging methods borrowed from flexible electronics. Integration with ultrathin silicon sensors, biodegradable antennas and dissolvable interconnects is advancing rapidly, driven by parallel progress in transient semiconductor research. As these threads converge, researchers envision complete diagnostic and therapeutic systems—power, electronics, antenna and all—that are implanted or swallowed, perform their function, and vanish, leaving nothing behind but a small, harmless chemical trace.

For patients, the implications extend beyond convenience. Eliminating extraction surgeries removes anesthesia risks, costs and anxiety; for pediatric and elderly populations especially, any procedure avoided is meaningful. For health systems, self-erasing devices could reduce long-term follow-up burdens. The research community is candid that clinical adoption will require years of validation, standardization of degradation timelines and regulatory frameworks adapted to hardware that is designed to fail safely. But the trajectory is clear: energy storage is joining the broader movement toward medical technology that respects the body’s own temporality, delivering function precisely when it is needed and then, quietly and completely, disappearing.

Subject of Research: Development of biodegradable, transient power sources for ingestible and implantable bioelectronics

Article Title: Bioresorbable batteries for transient ingestible bioelectronics

Article References: Say, M. G., Erus, A., Morgan, L., Cai, Y., Moon, I., Park, Y.-G., DeBruyn, B., Kang, Z., Parvataneni, K., Akouissi, O., Girand, O., You, S. S., Pettinari, A., Guevara, A., Laidlaw, B., Schmidt, K., Fabian, N., Hayward, A., & Traverso, G. (2026). Bioresorbable batteries for transient ingestible bioelectronics. Nature Chemical Engineering. https://doi.org/10.1038/s44286-026-00443-7

Image Credits: AI Generated

DOI: 10.1038/s44286-026-00443-7

Keywords: bioresorbable batteries, transient electronics, ingestible devices, biodegradable implants, zinc battery, magnesium anode, hydrogel electrolyte, biocompatibility, implantable sensors, transient pacemaker, biomedical engineering, dissolvable electronics

Microjoining, as the authors define it, covers the joining of thin sheets up to 0.5 millimeters thick and fine wires with diameters no greater than one millimeter. The scale is not merely a smaller version of conventional welding. At these dimensions, physics itself changes character. Surface and interfacial effects begin to dominate bulk behavior, capillary forces can overwhelm gravity, and the limited material volume means heat transfer and solidification kinetics behave in ways that defy macroscale intuition. The result is that micro-joints carry thermal stresses and microstructures fundamentally different from their large-scale counterparts, making microjoining a discipline that demands its own scientific foundation rather than a simple downscaling of established practice.

The range of materials involved is striking. Metals remain the workhorses of the field, with stainless steel, titanium and magnesium alloys long favored for their mechanical performance, biocompatibility and cost-effectiveness. Stainless steel has served in surgical implants since the 1920s, but modern demands have pushed far beyond. Shape-memory alloys, particularly nickel-titanium or NiTi, owe their indispensability to reversible martensitic phase transformations that produce the shape memory effect and superelasticity, properties exploited in orthodontic archwires, stents and guidewires. Laser microwelding between NiTi microtubes and platinum-iridium wires has even been used to tailor transformation temperatures for specific device needs. Biodegradable magnesium and zinc alloys, noble metals such as gold, silver and platinum that enhance X-ray visibility, and refractory metals like niobium that serve as biocompatible intermediates round out an expanding metallic palette.

Polymers and composites bring their own advantages, particularly deformability, corrosion resistance and machinability. Laser welding has successfully bonded three-dimensional polymer fabrics for orthopedic applications, achieving reliable fiber-to-fiber joints without surface damage. Researchers have also microjoined polymers to dissimilar materials, as in polyimide-titanium and PETG-stainless steel systems, and integrated metal-coated chips into the inner surfaces of polymer stents. Commercially, the FARAWAVE pulsed field ablation catheter relies on joining metal-ring electrodes to polymer wires, balancing flexible motion with X-ray mapping capability. The looming replacement of PFAS with environmentally sustainable polymers, the authors note, may create new joining challenges as unfamiliar materials enter the production pipeline.

Ceramics present the steepest hurdles. Bioinert oxides and nitrides, bioresorbable calcium phosphates and bioactive glasses are prized for bone and dental restoration, but their high melting points and poor deformability restrict both fusion and solid-state joining at the microscale. Soldering, brazing and adhesive bonding dominate instead. Implantable neural stimulators demonstrate the feasibility of micro-brazing platinum-iridium pins into ceramic substrates, and hermetically packaged neurostimulation devices have been built by co-firing ceramics with platinum tracks, pointing toward a ceramic-rich future for next-generation implantables.

Four families of joining methods have been adapted to the microscale. Fusion welding, the most widely used, employs laser beams, electron beams, plasma arcs or contact-based resistance heating to melt and re-solidify base materials. Laser microwelding leads the field thanks to its high energy density and precise controllability. Yet fusion welding of dissimilar metals reveals the discipline’s central difficulty: when NiTi wires are laser welded to stainless steel, rapid heating and cooling produce uneven mixing and non-equilibrium solidification, filling the fusion zone with brittle intermetallic compounds that cripple joint strength. Resistance microwelding offers an elegant workaround. Using miniature copper-chromium electrodes roughly one millimeter in diameter, researchers have squeezed molten liquid out of the interface entirely, achieving quasi-solid-state direct bonding between NiTi and stainless steel while preserving flexible deformability on one side and superelasticity on the other.

Solid-state welding sidesteps melting altogether, relying on interdiffusion under pressure through friction, ultrasonic vibration or diffusion bonding. Ultrasonic microwelding of thin titanium sheets produces interfacial regions less than five micrometers thick, while vapor foil actuator welding joins NiTi wires to brass sheets without significant alloy intermixing, suppressing intermetallic formation. Brazing and soldering with low-melting-point fillers enable complex configurations, exemplified by furnace micro-brazing of shape-memory alloy wires into honeycomb stent architectures that retain superelastic response, and laser micro-brazing of platinum rings to copper-coated stainless steel wires for interventional devices requiring both radiopacity and signal feedback. Adhesive bonding remains indispensable for assembling thermoplastic microfluidic substrates used in bioanalysis and diagnostics, though surface preparation through plasma cleaning proves critical to joint quality.

Evaluating micro-joints for biomedical service requires far more than simple strength measurements. Digital image correlation has revealed high strain localization around weld nuggets in resistance-welded shape-memory alloy sheets, identifying crack nucleation sites, while scanning electron microscopy enables in-situ testing of wire joints too small for optical strain mapping. Functional performance matters as much as mechanics: arc-welded NiTi wires show markedly increased residual strain during superelastic cycling compared with base material, attributed to grain coarsening and microstructural evolution in the weld zone. Thermomechanical fatigue testing under cyclic martensitic transformations shows welded joints suffer reduced fatigue life, though post-weld heat treatment can homogenize microstructure and restore durability. Corrosion and biocompatibility add further complexity, with studies showing that beneficial alloying element mixing during fusion welding can improve passive film formation, while toxic elements like copper, cobalt and nickel must be rigorously avoided.

The perspective outlines four frontiers for the coming decade. Smart devices such as MEMS sensor-equipped fractional flow reserve guidewires will demand increasingly sophisticated multi-material joining strategies combining soldering, adhesive bonding and fusion welding in a single assembly. Process optimization offers immediate gains, as demonstrated by electromagnetic-field-assisted laser microwelding of NiTi to stainless steel, where induced Lorentz forces drive the liquid fusion zone toward the steel side, limiting brittle iron-titanium phases and boosting tensile strength by 28 percent and ductility by 137 percent. Deeper fundamental understanding will come from in-situ X-ray imaging, smoothed particle hydrodynamics simulations and density functional theory calculations applied at microscale resolution. Finally, the authors call for standardized joining and testing protocols, whose current absence limits cross-study comparison and industrial adoption. With human lifespans lengthening and medical technology accelerating, the researchers argue that microjoining stands poised to become a defining enabler of the next generation of reliable, multifunctional biomedical devices.

Subject of Research: Microjoining technologies for the fabrication of biomedical devices

Article Title: Microjoining for biomedical device fabrication: a perspective

Article References: Zhang, K., Zhou, Y. N., & Peng, P. (2026). Microjoining for biomedical device fabrication: a perspective. Advanced Materials Joining, 1(1), Article 3. https://doi.org/10.1007/s44500-026-00006-z

Image Credits: AI Generated

DOI: 10.1007/s44500-026-00006-z

Keywords: microjoining, biomedical devices, laser microwelding, shape memory alloys, NiTi, stents, resistance welding, solid-state welding, brazing, biocompatibility, intermetallic compounds, implantable sensors